Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B‐cell lymphomas Meeting Abstract
| Authors: | Jagadeesh, D.; Horwitz, S.; Bartlett, N. L.; Advani, R.; Jacobsen, E.; Duvic, M.; Gautman, A.; Rao, S.; Onsum, M.; Fanale, M.; Kim, Y. |
| Abstract Title: | Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B‐cell lymphomas |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 470 |
| End Page: | 471 |
| Language: | English |
| ACCESSION: | 137029167 |
| DOI: | 10.1002/hon.149_2631 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting abstract: 438 -- Accession Number: 137029167 -- Entry Date: In Process -- Revision Date: 20190620 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
